Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Leukemia|March 16, 2019
Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8<sup>+</sup> cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapyJooeun Bae, Mehmet Samur, Paul Richardson, et al.Blood Advances|March 21, 2024
Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implicationsEric Letouzé, Philippe Moreau, Nikhil Munshi, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2013
Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cellsJooeun Bae, Aditya Munshi, Cheng Li, et al.Scientific Reports|August 9, 2017
MUC1-C activates EZH2 expression and function in human cancer cellsHasan Rajabi, Masayuki Hiraki, Ashujit Tagde, et al.Blood|August 19, 2022
The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMMNicholas Stong, María Ortiz-Estévez, Fadi Towfic, et al.Oncoimmunology|May 6, 2015
Heteroclitic XBP1 peptides evoke tumor-specific memory cytotoxic T lymphocytes against breast cancer, colon cancer, and pancreatic cancer cellsJooeun Bae, Mehmet Samur, Aditya Munshi, et al.Oncogene|August 23, 2019
MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cellsHasan Rajabi, Tsuyoshi Hata, Wei Li, et al.Oncogene|October 3, 2019
Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cellsHasan Rajabi, Tsuyoshi Hata, Wei Li, et al.Blood|October 12, 2022
Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myelomaNaser Ansari-Pour, Mehmet Samur, Erin Flynt, et al.Blood|October 27, 2023
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myelomaJooeun Bae, Shuichi Kitayama, Zach Herbert, et al.Pageof 3